Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 10;13(8):1423.
doi: 10.3390/genes13081423.

Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes

Affiliations

Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes

Helena M Feenstra et al. Genes (Basel). .

Abstract

Background: This study aimed to compare phenotype−genotype correlation in patients with Usher syndrome (USH) to those with autosomal recessive retinitis pigmentosa (NS-ARRP) caused by genes associated with Usher syndrome. Methods: Case notes of patients with USH or NS-ARRP and a molecularly confirmed diagnosis in genes associated with Usher syndrome were reviewed. Phenotypic information, including the age of ocular symptoms, hearing impairment, visual acuity, Goldmann visual fields, fundus autofluorescence (FAF) imaging and spectral domain optical coherence tomography (OCT) imaging, was reviewed. The patients were divided into three genotype groups based on variant severity for genotype-phenotype correlations. Results: 39 patients with Usher syndrome and 33 patients with NS-ARRP and a molecular diagnosis in an Usher syndrome-related gene were identified. In the 39 patients diagnosed with Usher syndrome, a molecular diagnosis was confirmed as follows: USH2A (28), MYO7A (4), CDH23 (2), USH1C (2), GPR98/VLGR1 (2) and PCDH15 (1). All 33 patients with NS-ARRP had variants in USH2A. Further analysis was performed on the patients with USH2A variants. USH2A patients with syndromic features had an earlier mean age of symptom onset (17.9 vs. 31.7 years, p < 0.001), had more advanced changes on FAF imaging (p = 0.040) and were more likely to have cystoid macular oedema (p = 0.021) when compared to USH2A patients presenting with non-syndromic NS-ARRP. Self-reported late-onset hearing loss was identified in 33.3% of patients with NS-ARRP. Having a syndromic phenotype was associated with more severe USH2A variants (p < 0.001). Eighteen novel variants in genes associated with Usher syndrome were identified in this cohort. Conclusions: Patients with Usher syndrome, whatever the associated gene in this cohort, tended to have an earlier onset of retinal disease (other than GPR98/VLGR1) when compared to patients presenting with NS-ARRP. Analysis of genetic variants in USH2A, the commonest gene in our cohort, showed that patients with a more severe genotype were more likely to be diagnosed with USH compared to NS-ARRP. USH2A patients with syndromic features have an earlier onset of symptoms and more severe features on FAF and OCT imaging. However, a third of patients diagnosed with NS-ARRP developed later onset hearing loss. Eighteen novel variants in genes associated with Usher syndrome were identified in this cohort, thus expanding the genetic spectrum of known pathogenic variants. An accurate molecular diagnosis is important for diagnosis and prognosis and has become particularly relevant with the advent of potential therapies for Usher-related gene

Keywords: USH2A; non-syndromic autosomal recessive retinitis pigmentosa (NS-ARRP); retinitis pigmentosa; syndromic retinitis pigmentosa; usher syndrome types 1, 2, 3.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Fundus autofluorescence (FAF) and optical coherence tomography (OCT) images in three compound heterozygous patients from our cohort showing the disease stages described by Fakin et al. [19] for USH2A variants. (A) FAF and OCT imaging of patient 50 with non-syndromic autosomal recessive retinitis pigmentosa phenotype that was compound heterozygous for USH2A variants c.2276G > T, p.(Cys759Phe) and c.11875_11876delCA. FAF images show a ring of raised AF surrounding the foveal region and patches of decreased AF in the mid-peripheral retina. OCT images showing central retinal preservation. (B) FAF and OCT imaging of patient 35 with USH that was compound heterozygous for USH2A c.9469C > T p.(Gln3157*) and the novel c.10586-1_10595delins13 variant. FAF images show an increased patch of raised AF surrounded by a region of reduced AF and also raised macular AF, which is surrounded by large patches of decreased AF that extend into and beyond the mid-peripheral retina. OCT images show loss of outer retinal layers. (C) FAF and OCT imaging for patient 12 with USH that was compound heterozygous for c.7932G-A, p.(Trp2644*), c.13331C > T p.(Pro4444Leu), and the variant of unknown significance c.6364G > T p.(Ala2122Ser). FAF images showed decreased foveal AF and decreased AF in the mid-peripheral retina. OCT images show a significant outer-retinal loss in the right eye and cystoid macular oedema in the left eye.
Figure 2
Figure 2
Fundus autofluorescence (FAF) and optical coherence tomography OCT imaging in patient 41, who was compound heterozygous for USH2A variants c.2299del and c.8740C > T, p.(Arg2914*). FAF images showed decreased AF signal in the mid-peripheral retinal, raised macular AF and speckled area of raised foveal AF. OCT images show bilateral central cystoid macular oedema.

References

    1. Blanco-Kelly F., Jaijo T., Aller E., Avila-Fernandez A., Lopez-Molina M.I., Gimenez A., Garcia-Sandoval B., Millan J.M., Ayuso C. Clinical aspects of Usher syndrome and the USH2A gene in a cohort of 433 patients. JAMA Ophthalmol. 2015;133:157–164. doi: 10.1001/jamaophthalmol.2014.4498. - DOI - PubMed
    1. Sengillo J.D., Cabral T., Schuerch K., Duong J., Lee W., Boudreault K., Xu Y., Justus S., Sparrow J.R., Mahajan V.B., et al. Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients. Sci. Rep. 2017;7:11170. doi: 10.1038/s41598-017-11679-y. - DOI - PMC - PubMed
    1. Pierrache L.H., Hartel B.P., van Wijk E., Meester-Smoor M.A., Cremers F.P., de Baere E., de Zaeytijd J., van Schooneveld M.J., Cremers C.W., Dagnelie G., et al. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. Ophthalmology. 2016;123:1151–1160. doi: 10.1016/j.ophtha.2016.01.021. - DOI - PubMed
    1. GeneReviews® Usher Syndrome Type I. [(accessed on 10 June 2022)]; Available online: https://www.ncbi.nlm.nih.gov/books/NBK1265/
    1. Toualbi L., Toms M., Moosajee M. USH2A-retinopathy: From genetics to therapeutics. Exp. Eye Res. 2020;201:108330. doi: 10.1016/j.exer.2020.108330. - DOI - PMC - PubMed

Publication types

Substances

Supplementary concepts